Validity of behavioral measures as proxies for HIV-related outcomes

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue SUPPL.3, 2014, Pages

  Zimmerman, Rick S ^a   Morisky, Donald E ^b   Harrison, Lana ^c   Mark, Hayley D ^d  

^a UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF DELAWARE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

behavior; biomarker; HIV; measurement; validity

Indexed keywords

BIOLOGICAL MARKER;

ALCOHOL INTOXICATION; ARTICLE; BEHAVIOR CHANGE; CONDOM USE; CONFIDENTIALITY; DIAGNOSTIC TEST; DRUG USE; FALSE POSITIVE RESULT; HAIR TESTING; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LAW ENFORCEMENT; MEDICATION COMPLIANCE; MORBIDITY; MORTALITY; PHARMACY; PRIORITY JOURNAL; PRIVACY; RISK FACTOR; SELF REPORT; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE USE; UNPROTECTED SEX; URINALYSIS;

ADOLESCENT; ADULT; BEHAVIOR; BIOLOGICAL MARKERS; DRUG MONITORING; FEMALE; HIV INFECTIONS; HUMANS; MALE; PROGNOSIS; SELF REPORT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904131047     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000241     Document Type: Article

References (47)

1. Macaluso M, Lawson L, Akers R, et al. Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure. Contraception. 1999;59:195-201.
2. Zenilman JM, Yuenger J, Galai N, et al. Polymerase chain reaction detection of Y chromosome sequences in vaginal fluid: Preliminary studies of a potential biomarker for sexual behavior. Sex Transm Dis. 2005; 32:90-94.
3. Zimmerman RS, Langer LM. Improving prevalence estimates of sensitive behaviors: The randomized lists technique and self-reported honesty. J Sex Res. 1995;32:107-117.
4. Upchurch DM, Lillard LA, Aneshensel CS, et al. Inconsistencies in reporting the occurrence and timing of first intercourse among adolescents. J Sex Res. 2002;39:197-206.
5. Rosenbaum JE. Reborn a virgin: Adolescents' retracting of virginity pledges and sexual histories. Am J Pub Health. 2006;96:1098-1103.
6. Palen LA, Smith EA, Caldwell LL, et al. Inconsistent reports of sexual intercourse among South African high school students. J Adoles Health. 2008;42:221-227.
7. Rosenbaum JE. Truth or consequences: The interoral consistency of adolescent self-report on the youth risk behavior survey. Am J Epi. 2009; 169:1388-1397.
8. Jaccard J, McDonald R, Wan CK, et al. The accuracy of self-reports of condom use and sexual behavior. J Appl Soc Psychol. 2002;32: 1863-1905.
9. Ghanem KG, Melendez JH, McNeil-Solis C, et al. Condom use and vaginal Y-chromosome detection: The specificity of a potential biomarker. Sex Transm Dis. 2007;34:620-623.
10. Jamshidi R, Penman-Aguilar A,Wiener J, et al. Detection of two biological markers of intercourse: Prostate-specific antigen and Y-chromosomal DNA. Contracep. 2013;88:749-757.
11. Gallo MF, Steiner MJ, Hobbs MM, et al. Biological markers of sexual activity: Tools for improving measurement in HIV/sexually transmitted infection prevention research. Sex Transm Dis. 2013;40: 447-452.
12. Udry JR, Morris NM. A method for validation of report sexual data. J Marriage Fam. 1967;29:443-446.
13. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: The validity of self-reported condom use. Sex Transm Dis. 1995;22:15-21.
14. Shew ML, Remafedi GJ, Bearinger LH, et al. The validity of self-reports condom use among adolescents. Sex Transm Dis. 1997;24:503-510.
15. Jadack RA, Yuenger J, Ghanem KG, et al. Polymerase chain reaction detecting of Y-chromosome sequences in vaginal fluid of women accessing a sexually transmitted disease clinic. Sex Transm Dis. 2006;33:22-25.
16. Gallo MF, Behets FM, Steiner MJ, et al. Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen. Sex Trans Dis. 2006;33:376-479.
17. Gallo MF, Behets FM, Steiner MJ, et al. Validity of self-reported "safe sex" among female sex workers in Mombasa, Kenya-PSA analysis. Int J STD AIDS. 2007;18:33-38.
18. Rose E, Di Clemente RJ, Wingood GM, et al. The validity of teens' and young adults' self-reported condom use. Arch Pediatr Adolesc Med. 2009;63:61-64.
19. Minnis AM, Steiner MJ, Gallo MF, et al. Biomarker validation of reports of recent sexual activity: Results of a randomized controlled study in Zibabwe. Am J Epidemiol. 2009;170:918-924.
20. Aho J, Koushik A, Diakite SL, et al. Biological validation of selfreported condom use among sex workers in Guinea. AIDS Behav. 2010;14:1287-1293.
21. Turner CF, Ku L, Rogers SM, et al. Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science. 1998;280:867-873.
22. Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Pub Health. 2005;27:281-291.
23. Zimmerman R, Atwood K, Cupp P. Methods for collecting data about sensitive topics. In: Di Clemente, Crosby, Salazar, eds. Methods for Health Promotion. San Francisco, CA: Jossey-Bass; 2006.
24. Leigh BC, Gillmore MR, Morrison, et al. Comparison of diary and retrospective measures for recording alcohol consumption and sexual activity. J Clin Epidem. 1998;51:119-127.
25. Borkenstein RF, Smith HW. The Breathalyzer and its applications. J Med Sci L. 1961;2:13-22.
26. Wish ED, O'Neil JA. Urine testing for drug use among male arrestees-United States 1989. MMWR. 1989;38:780-783.
27. Harrison LD, Hughes A, eds. The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates. Washington, DC: Supt of Docs US Govt Print Off; 1997. NIDA Research Monograph 167. Available at: http://www.nida.nih.gov/pdf/monographs/monograph167/download167. html. Accessed February 9, 2014.
28. Gwet KL. Advanced Analytics. In: Handbook of inter-rate reliability. 3rd ed. Gaithersburg, MD: LLC; 2012.
29. Harrison LD. The validity of self-reported data on drug use. J Drug Issues. 1995;25:91-111.
30. Magura S, Kang S-Y. Validity of self-reported drug use in high risk populations: A meta-analytic review. Subst Use Misuse. 1996;31: 1131-1151.
31. Harrison LD, Martin SS, Enev T, et al. Comparing Drug Testing and Self-Report of Drug Use Among Youths and Young Adults in the General Population. DHHS Publication No. SMA 07-4249. Rockville, MD: SAMHSA; Available at: http://www.oas.samhsa.gov/validity/drugTest. cfm. Accessed February 9, 2014.
32. Center for Substance Abuse Prevention. Drug Testing Advisory Board. Minutes, September 11, 2013. Bethesda, MD: SAMHSA; 2013.
33. Liu H, Golin CE, Miller LG, et al. How best to measure medication adherence? A comparison study of multiple measures of adherence to inhibitors of the HIV protease. Ann Int Med. 2006;134:968-977.
34. Kalichman SC, Amaral CM, Swetzes C, et al. A simple single item rating scale to measure adherence: Further evidence for convergent validity. J Intl Assoc Phys AIDS Care. 2009;8:367-374.
35. Gifford AL, Bormann JE, Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquire Immune Defic Syndr. 2000;23:386-395.
36. Parker CS, Chen Z, Kimmel SE. Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: Results from the IN-RANGE study. J Gen Intern Med. 2007;22:1254-1259.
37. Mosca C, Castel-Branco M, Ribeiro-Rama AC, et al. Assessing the impact of multi-compartment compliance aids on clinical outcomes in the elderly: A pilot study. Int J Clin Pharm. 2014;36:98-104.
38. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Final response. J Clin Epidemio. 2011;64: 258-263.
39. Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008;197:S272-S278.
40. Williams AB, Amico KR, Bova C, et al. A proposal for quality standards for measuring medication adherence in research. AIDS Behav. 2013;17: 284-297.
41. Kahana SY, Rohan J, Allison S, et al. A meta-analysis of adherence to antiretroviral therapy and virologic responses in HIV-infected children, adolescents, and young adults. AIDS Behav. 2013;17:41-60.
42. Liu H, Wilson IB, Goggin K, et al. MACH14: A multi-site collaboration on ART adherence among 14 institutions. AIDS Behav. 2013;17:127-141.
43. Wise J, Operario D. Use of electronic reminder devices to improve adherence to antiretroviral therapy: A systematic review. AIDS Patient Care STDS. 2008;22:495-504.
44. Leventhal H, Cameron L. Behavioral theories and the problem of compliance. Patient Educ Couns. 1987;10:117-138.
45. Vervloet M, Linn JA, van Weert DH, et al. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: A systematic review of the literature. J Am Med Inform Assoc. 2012;19:696-704.
46. Pequegnat W, Fishbein M, Celentano D, et al. NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: A position statement. Sex Trans Dis. 2000;27:127-132.
47. Fishbein M, Pequegnat W. Evaluating AIDS prevention interventions using behavioral and biological outcome measures. Sex Trans Dis. 2000;27:100-110.